Agency Forms Undergoing Paperwork Reduction Act Review, 19376-19377 [2017-08490]
Download as PDF
<![CDATA[
19376
Federal Register / Vol. 82, No. 80 / Thursday, April 27, 2017 / Notices
LEAD questionnaire is now proposed as
an annual reporting requirement for
awardees under the FY17 FOA, as the
ALPA questionnaire.
There is no cost to the respondents
other than their time. The total annual
time burden requested is six hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total
burden
hours
Type of respondent
Form name
State And Local Governments (or
their bona fide fiscal agents).
Awardee Lead Profile Assessment
(ALPA) Questionnaire—Web survey.
ALPA Questionnaire—Word format
40
1
7/60
5
5
1
7/60
1
...........................................................
........................
........................
........................
6
Total ...........................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–08539 Filed 4–26–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–1074]
mstockstill on DSK30JT082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
VerDate Sep<11>2014
17:07 Apr 26, 2017
Jkt 241001
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Colorectal Cancer Control Program
(CRCCP) Monitoring Activities (OMB
Control Number 0920–1074, expires 06/
30/2019)—Revision—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a revision to the
approved information collection under
OMB Control Number 0920–1074. CDC
proposes use of a revised grantee survey
instrument, as well as a revised cliniclevel data collection template. The
number of respondents will also
decrease from 31 to 30 grantees, and the
total estimated annualized burden will
decrease.
Colorectal cancer (CRC) is the second
leading cause of death from cancer in
the United States among cancers that
affect both men and women. CRC
screening has been shown to reduce
incidence of and death from the disease.
Screening for CRC can detect disease
early when treatment is more effective
and prevent cancer by finding and
removing precancerous polyps. Of
individuals diagnosed with early stage
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
CRC, more than 90% live five or more
years. To reduce CRC morbidity,
mortality, and associated costs, use of
CRC screening tests must be increased
among age-eligible adults with the
lowest CRC screening rates.
The purpose of the Colorectal Cancer
Control Program (CRCCP): Organized
Approaches to Increase Colorectal
Cancer Screening (CDC–RFA–DP15–
1502), is to increase CRC screening rates
among an applicant defined target
population of persons 50–75 years of
age within a partner health system
serving a defined geographical area or
disparate population. The CRCCP
includes 30 grantees that are state
governments or bona-fide agents,
universities, and tribal organizations.
The CRCCP was significantly
redesigned in 2015 and has two
components. Under Component 1, all
grantees receive funding to support
partnerships with health systems to
implement up to four priority evidencebased interventions (EBIs) described in
the Guide to Community Preventive
Services, as well as other supporting
activities (SAs). Grantees must
implement at least two EBIs in each
partnering health system. Under
Component 2, six of the 30 grantees
provide direct screening and follow-up
clinical services for a limited number of
individuals aged 50–64 in the program’s
priority population who are
asymptomatic, at average risk for CRC,
have inadequate or no health insurance
for CRC screening, and are low income.
Two forms of data collection have
been implemented to assess program
processes and outcomes. In Program
Year 1, the annual grantee survey
monitored grantee program
implementation, including (1) program
management, (2) implementation of the
EBIs and SAs, (3) health information
technology (IT), (4) partnerships, (5)
data use, (6) training and technical
assistance (TA), and (7) clinical service
delivery (for programs receiving
E:\FR\FM\27APN1.SGM
27APN1
19377
Federal Register / Vol. 82, No. 80 / Thursday, April 27, 2017 / Notices
Component 2 funding only). Clinic-level
data collection assessed CRCCP’s
primary outcome of interest—CRC
screening rates within partner health
systems—by measuring: (1) Partner
health system, clinic, and patient
population characteristics, (2) reporting
period (for screening rates), (3) Chart
review screening rate data, (4)
Electronic Health Record (EHR)
screening rate, and (5) Priority evidencebased EBIs and SAs.
Based on feedback from grantees and
internal subject matter experts, CDC
proposes use of updated data collection
implementation activities, evaluate
outcomes, and identify grantee technical
assistance needs. In addition, data
collected will inform program
improvement and help identify
successful activities that need to be
maintained, replicated, or expanded.
OMB approval is requested for three
years. The total estimated annualized
burden hours have decreased from 210
to 204 hours. There are no costs to
respondents other than their time.
instruments. Specifically, CDC plans to
implement a revised CRCCP grantee
survey that eliminates questions related
to EBI and SA implementation as these
data are more accurately reported at the
clinic level. Conversely, CDC will
implement a revised CRCCP clinic-level
data collection template with additional
data variables related to EBI and SA
implementation, as well as monitoring
and evaluation activities, at the clinic
level.
Redesigned data elements will enable
CDC to better gauge progress in meeting
CRCCP program goals and monitor
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Type of respondent
Form name
CRCCP Grantees ...........................................
CRCCP Annual Grantee Survey ....................
CRCCP Clinic-level Information Collection
Template.
30
30
1
12
Average
burden per
response
(in hrs)
24/60
32/60
Total .........................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–08490 Filed 4–26–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Voluntary Acknowledgement of
Paternity and Required Data Elements
for Paternity Establishment Affidavits.
OMB No.: 0970–0171.
Description: Section 466(a)(5)(C) of
the Social Security Act requires States
to enact laws ensuring a simple civil
process for voluntarily acknowledging
paternity via an affidavit. The
development and use of an affidavit for
the voluntary acknowledgment of
paternity would include the minimum
requirements of the affidavit specified
by the Secretary under section 452(a)(7)
and give full faith and credit to such an
affidavit signed in any other State
according to its procedures. The State
must provide that, before a mother and
putative father can sign a voluntary
acknowledgement of paternity, the
mother and putative father must be
given notice, orally and in writing of the
alternatives to, the legal consequences
of, and the rights (including any rights,
if one parent is a minor, due to minority
status) and responsibilities of
acknowledging paternity. The affidavits
will be used by hospitals, birth record
agencies, and other entities participating
in the voluntary paternity establishment
program to collect information from the
parents of nonmarital children.
Respondents: The parents of
nonmarital children and State and
Tribal IV–D agencies, hospitals, birth
record agencies and other entities
participating in the voluntary paternity
establishment program.
ANNUAL BURDEN ESTIMATES
Number of
respondents/
partner
Instrument
mstockstill on DSK30JT082PROD with NOTICES
Training ............................................................................................................
Paternity Acknowledgment Process ................................................................
Data Elements .................................................................................................
Data Elements .................................................................................................
Estimated Total Annual Burden
Hours: 782,003
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
VerDate Sep<11>2014
21:55 Apr 26, 2017
Jkt 241001
130,330
2,606,596
54
2,606,596
Planning, Research and Evaluation, 330
C Street SW., Washington, DC 20201.
Attention Reports Clearance Officer. All
requests should be identified by the title
of the information collection. Email
address: infocollection@acf.hhs.gov.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Number of
responses per
respondent/
partner
1
1
1
1
Average
burden hours
per response
1
0.17
1
.08
Total burden
hours
130,300
443,121
54
208,528
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
E:\FR\FM\27APN1.SGM
27APN1
]]>Agencies
[Federal Register Volume 82, Number 80 (Thursday, April 27, 2017)]
[Notices]
[Pages 19376-19377]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08490]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-1074]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Colorectal Cancer Control Program (CRCCP) Monitoring Activities
(OMB Control Number 0920-1074, expires 06/30/2019)--Revision--National
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a revision to the approved information collection
under OMB Control Number 0920-1074. CDC proposes use of a revised
grantee survey instrument, as well as a revised clinic-level data
collection template. The number of respondents will also decrease from
31 to 30 grantees, and the total estimated annualized burden will
decrease.
Colorectal cancer (CRC) is the second leading cause of death from
cancer in the United States among cancers that affect both men and
women. CRC screening has been shown to reduce incidence of and death
from the disease. Screening for CRC can detect disease early when
treatment is more effective and prevent cancer by finding and removing
precancerous polyps. Of individuals diagnosed with early stage CRC,
more than 90% live five or more years. To reduce CRC morbidity,
mortality, and associated costs, use of CRC screening tests must be
increased among age-eligible adults with the lowest CRC screening
rates.
The purpose of the Colorectal Cancer Control Program (CRCCP):
Organized Approaches to Increase Colorectal Cancer Screening (CDC-RFA-
DP15-1502), is to increase CRC screening rates among an applicant
defined target population of persons 50-75 years of age within a
partner health system serving a defined geographical area or disparate
population. The CRCCP includes 30 grantees that are state governments
or bona-fide agents, universities, and tribal organizations.
The CRCCP was significantly redesigned in 2015 and has two
components. Under Component 1, all grantees receive funding to support
partnerships with health systems to implement up to four priority
evidence-based interventions (EBIs) described in the Guide to Community
Preventive Services, as well as other supporting activities (SAs).
Grantees must implement at least two EBIs in each partnering health
system. Under Component 2, six of the 30 grantees provide direct
screening and follow-up clinical services for a limited number of
individuals aged 50-64 in the program's priority population who are
asymptomatic, at average risk for CRC, have inadequate or no health
insurance for CRC screening, and are low income.
Two forms of data collection have been implemented to assess
program processes and outcomes. In Program Year 1, the annual grantee
survey monitored grantee program implementation, including (1) program
management, (2) implementation of the EBIs and SAs, (3) health
information technology (IT), (4) partnerships, (5) data use, (6)
training and technical assistance (TA), and (7) clinical service
delivery (for programs receiving
[[Page 19377]]
Component 2 funding only). Clinic-level data collection assessed
CRCCP's primary outcome of interest--CRC screening rates within partner
health systems--by measuring: (1) Partner health system, clinic, and
patient population characteristics, (2) reporting period (for screening
rates), (3) Chart review screening rate data, (4) Electronic Health
Record (EHR) screening rate, and (5) Priority evidence-based EBIs and
SAs.
Based on feedback from grantees and internal subject matter
experts, CDC proposes use of updated data collection instruments.
Specifically, CDC plans to implement a revised CRCCP grantee survey
that eliminates questions related to EBI and SA implementation as these
data are more accurately reported at the clinic level. Conversely, CDC
will implement a revised CRCCP clinic-level data collection template
with additional data variables related to EBI and SA implementation, as
well as monitoring and evaluation activities, at the clinic level.
Redesigned data elements will enable CDC to better gauge progress
in meeting CRCCP program goals and monitor implementation activities,
evaluate outcomes, and identify grantee technical assistance needs. In
addition, data collected will inform program improvement and help
identify successful activities that need to be maintained, replicated,
or expanded.
OMB approval is requested for three years. The total estimated
annualized burden hours have decreased from 210 to 204 hours. There are
no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hrs)
----------------------------------------------------------------------------------------------------------------
CRCCP Grantees........................ CRCCP Annual Grantee 30 1 24/60
Survey.
CRCCP Clinic-level 30 12 32/60
Information Collection
Template.
-----------------------------------------------
Total.............................
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-08490 Filed 4-26-17; 8:45 am]
BILLING CODE 4163-18-P
